Author: "Vasir, Baldev" - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Vasir, Baldev"' showing total 208 results

Start Over Author "Vasir, Baldev"

208 results on '"Vasir, Baldev"'

1. Supplementary Table 2 from Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

Author: Rosenblatt, Jacalyn, primary, Avivi, Irit, primary, Vasir, Baldev, primary, Uhl, Lynne, primary, Munshi, Nikhil C., primary, Katz, Tami, primary, Dey, Bimalangshu R., primary, Somaiya, Poorvi, primary, Mills, Heidi, primary, Campigotto, Federico, primary, Weller, Edie, primary, Joyce, Robin, primary, Levine, James D., primary, Tzachanis, Dimitrios, primary, Richardson, Paul, primary, Laubach, Jacob, primary, Raje, Noopur, primary, Boussiotis, Vassiliki, primary, Yuan, Yan Emily, primary, Bisharat, Lina, primary, Held, Viki, primary, Rowe, Jacob, primary, Anderson, Kenneth, primary, Kufe, Donald, primary, and Avigan, David, primary
Published: 2023
Full Text: View/download PDF

2. Supplementary Table 1 from Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

Author: Rosenblatt, Jacalyn, primary, Avivi, Irit, primary, Vasir, Baldev, primary, Uhl, Lynne, primary, Munshi, Nikhil C., primary, Katz, Tami, primary, Dey, Bimalangshu R., primary, Somaiya, Poorvi, primary, Mills, Heidi, primary, Campigotto, Federico, primary, Weller, Edie, primary, Joyce, Robin, primary, Levine, James D., primary, Tzachanis, Dimitrios, primary, Richardson, Paul, primary, Laubach, Jacob, primary, Raje, Noopur, primary, Boussiotis, Vassiliki, primary, Yuan, Yan Emily, primary, Bisharat, Lina, primary, Held, Viki, primary, Rowe, Jacob, primary, Anderson, Kenneth, primary, Kufe, Donald, primary, and Avigan, David, primary
Published: 2023
Full Text: View/download PDF

3. Supplementary Figure Legends from MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells

Author: Stroopinsky, Dina, primary, Rosenblatt, Jacalyn, primary, Ito, Keisuke, primary, Mills, Heidi, primary, Yin, Li, primary, Rajabi, Hasan, primary, Vasir, Baldev, primary, Kufe, Turner, primary, Luptakova, Katarina, primary, Arnason, Jon, primary, Nardella, Caterina, primary, Levine, James D., primary, Joyce, Robin M., primary, Galinsky, Ilene, primary, Reiter, Yoram, primary, Stone, Richard M., primary, Pandolfi, Pier Paolo, primary, Kufe, Donald, primary, and Avigan, David, primary
Published: 2023
Full Text: View/download PDF

4. Supplementary Figure 6 from Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

Author: Raina, Deepak, primary, Ahmad, Rehan, primary, Joshi, Maya Datt, primary, Yin, Li, primary, Wu, Zekui, primary, Kawano, Takeshi, primary, Vasir, Baldev, primary, Avigan, David, primary, Kharbanda, Surender, primary, and Kufe, Donald, primary
Published: 2023
Full Text: View/download PDF

5. Data from MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells

Author: Stroopinsky, Dina, primary, Rosenblatt, Jacalyn, primary, Ito, Keisuke, primary, Mills, Heidi, primary, Yin, Li, primary, Rajabi, Hasan, primary, Vasir, Baldev, primary, Kufe, Turner, primary, Luptakova, Katarina, primary, Arnason, Jon, primary, Nardella, Caterina, primary, Levine, James D., primary, Joyce, Robin M., primary, Galinsky, Ilene, primary, Reiter, Yoram, primary, Stone, Richard M., primary, Pandolfi, Pier Paolo, primary, Kufe, Donald, primary, and Avigan, David, primary
Published: 2023
Full Text: View/download PDF

6. Supplementary Figure 2 from MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells

Author: Stroopinsky, Dina, primary, Rosenblatt, Jacalyn, primary, Ito, Keisuke, primary, Mills, Heidi, primary, Yin, Li, primary, Rajabi, Hasan, primary, Vasir, Baldev, primary, Kufe, Turner, primary, Luptakova, Katarina, primary, Arnason, Jon, primary, Nardella, Caterina, primary, Levine, James D., primary, Joyce, Robin M., primary, Galinsky, Ilene, primary, Reiter, Yoram, primary, Stone, Richard M., primary, Pandolfi, Pier Paolo, primary, Kufe, Donald, primary, and Avigan, David, primary
Published: 2023
Full Text: View/download PDF

7. Data from Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

Author: Raina, Deepak, primary, Ahmad, Rehan, primary, Joshi, Maya Datt, primary, Yin, Li, primary, Wu, Zekui, primary, Kawano, Takeshi, primary, Vasir, Baldev, primary, Avigan, David, primary, Kharbanda, Surender, primary, and Kufe, Donald, primary
Published: 2023
Full Text: View/download PDF

8. Supplementary Figure 5 from Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

Author: Raina, Deepak, primary, Ahmad, Rehan, primary, Joshi, Maya Datt, primary, Yin, Li, primary, Wu, Zekui, primary, Kawano, Takeshi, primary, Vasir, Baldev, primary, Avigan, David, primary, Kharbanda, Surender, primary, and Kufe, Donald, primary
Published: 2023
Full Text: View/download PDF

9. Supplementary Figure 7 A-B from Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

Author: Raina, Deepak, primary, Ahmad, Rehan, primary, Joshi, Maya Datt, primary, Yin, Li, primary, Wu, Zekui, primary, Kawano, Takeshi, primary, Vasir, Baldev, primary, Avigan, David, primary, Kharbanda, Surender, primary, and Kufe, Donald, primary
Published: 2023
Full Text: View/download PDF

10. Supplementary Figure 1A-C from Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

Author: Raina, Deepak, primary, Ahmad, Rehan, primary, Joshi, Maya Datt, primary, Yin, Li, primary, Wu, Zekui, primary, Kawano, Takeshi, primary, Vasir, Baldev, primary, Avigan, David, primary, Kharbanda, Surender, primary, and Kufe, Donald, primary
Published: 2023
Full Text: View/download PDF

11. Supplementary Figure 4 from Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

Author: Raina, Deepak, primary, Ahmad, Rehan, primary, Joshi, Maya Datt, primary, Yin, Li, primary, Wu, Zekui, primary, Kawano, Takeshi, primary, Vasir, Baldev, primary, Avigan, David, primary, Kharbanda, Surender, primary, and Kufe, Donald, primary
Published: 2023
Full Text: View/download PDF

12. Supplementary Materials, Figure Legends 1-7 from Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

Author: Raina, Deepak, primary, Ahmad, Rehan, primary, Joshi, Maya Datt, primary, Yin, Li, primary, Wu, Zekui, primary, Kawano, Takeshi, primary, Vasir, Baldev, primary, Avigan, David, primary, Kharbanda, Surender, primary, and Kufe, Donald, primary
Published: 2023
Full Text: View/download PDF

13. Supplementary Figure 2 from Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

Author: Raina, Deepak, primary, Ahmad, Rehan, primary, Joshi, Maya Datt, primary, Yin, Li, primary, Wu, Zekui, primary, Kawano, Takeshi, primary, Vasir, Baldev, primary, Avigan, David, primary, Kharbanda, Surender, primary, and Kufe, Donald, primary
Published: 2023
Full Text: View/download PDF

14. Supplementary Figure 3 from Direct Targeting of the Mucin 1 Oncoprotein Blocks Survival and Tumorigenicity of Human Breast Carcinoma Cells

Author: Raina, Deepak, primary, Ahmad, Rehan, primary, Joshi, Maya Datt, primary, Yin, Li, primary, Wu, Zekui, primary, Kawano, Takeshi, primary, Vasir, Baldev, primary, Avigan, David, primary, Kharbanda, Surender, primary, and Kufe, Donald, primary
Published: 2023
Full Text: View/download PDF

15. Supplementary Figure 1 from MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells

Author: Stroopinsky, Dina, primary, Rosenblatt, Jacalyn, primary, Ito, Keisuke, primary, Mills, Heidi, primary, Yin, Li, primary, Rajabi, Hasan, primary, Vasir, Baldev, primary, Kufe, Turner, primary, Luptakova, Katarina, primary, Arnason, Jon, primary, Nardella, Caterina, primary, Levine, James D., primary, Joyce, Robin M., primary, Galinsky, Ilene, primary, Reiter, Yoram, primary, Stone, Richard M., primary, Pandolfi, Pier Paolo, primary, Kufe, Donald, primary, and Avigan, David, primary
Published: 2023
Full Text: View/download PDF

16. Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma

Author: Rosenblatt, Jacalyn, Vasir, Baldev, Uhl, Lynne, Blotta, Simona, MacNamara, Claire, Somaiya, Poorvi, Wu, Zekui, Joyce, Robin, Levine, James D., Dombagoda, Dilani, Yuan, Yan Emily, Francoeur, Karen, Fitzgerald, Donna, Richardson, Paul, Weller, Edie, Anderson, Kenneth, Kufe, Donald, Munshi, Nikhil, and Avigan, David
Published: 2011
Full Text: View/download PDF

17. Lenalidomide enhances anti-myeloma cellular immunity

Author: Luptakova, Katarina, Rosenblatt, Jacalyn, Glotzbecker, Brett, Mills, Heidi, Stroopinsky, Dina, Kufe, Turner, Vasir, Baldev, Arnason, Jon, Tzachanis, Dimitri, Zwicker, Jeffrey I., Joyce, Robin M., Levine, James D., Anderson, Kenneth C., Kufe, Donald, and Avigan, David
Published: 2013
Full Text: View/download PDF

18. Fusion of dendritic cells with multiple myeloma cells results in maturation and enhanced antigen presentation

Author: Vasir, Baldev, Borges, Virginia, Wu, Zekui, Grosman, Daren, Rosenblatt, Jacalyn, Irie, Masaki, Anderson, Kenneth, Kufe, Donald, and Avigan, David
Published: 2005

19. CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation

Author: Crawford, Keith, Stark, Aleksandra, Kitchens, Betsy, Sternheim, Kerry, Pantazopoulos, Vassilios, Triantafellow, Ellen, Wang, Zhigang, Vasir, Baldev, Larsen, Charles E., Gabuzda, Dana, Reinherz, Ellis, and Alper, Chester A.
Published: 2003
Full Text: View/download PDF

20. Hypoxia Induces Vascular Endothelial Growth Factor Gene and Protein Expression in Cultured Rat Islet Cells

Author: Vasir, Baldev, Aiello, Lloyd Paul, Yoon, Kun-Ho, Quickel, Robert R., Bonner-Weir, Susan, and Weir, Gordon C.
Published: 1998

21. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metatastic Breast Cancer

Author: Kufe, Donald, primary, Vasir, Baldev, primary, and Avigan, David, primary
Published: 2012
Full Text: View/download PDF

22. Essential role of vif in establishing productive HIV-1 infection in peripheral blood T lymphocytes and monocyte/macrophages

Author: Gabuzda, Dana H., Li, Haodong, Lawrence, Katharine, Vasir, Baldev S., Crawford, Keith, and Langhoff, Erik
Subjects: HIV (Viruses) -- Reproduction, Health
Abstract: The vif protein produced by HIV is apparently essential for viral reproduction. Researchers mixed viral DNA with and without the sequence for vif with cell cultures containing T lymphocytes, monocytes and macrophages. They determined viral production by measuring levels of the p24 antigen and the viral enzyme reverse transcriptase. Cultures with an intact vif gene produced virus within nine days. However, cultures with the mutant vif DNA did not produce detectable virus. The exact role of the vif protein is not known, but it is probably involved in virus assembly or maturation.
Published: 1994

23. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metatastic Breast Cancer

Author: Kufe, Donald W., primary, Avagan, David, primary, and Vasir, Baldev, primary
Published: 2010
Full Text: View/download PDF

24. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metastatic Breast Cancer. Addendum

Author: Kufe, Donald W., primary, Vasir, Baldev, primary, and Avigan, David, primary
Published: 2009
Full Text: View/download PDF

25. Loss of Β Cell Differentiation of Diabetes is Associated with Increased c-myc Expression and Cell Hypertrophy

Author: JONAS, JEAN-CHRISTOPH, SHARMA, ARUN, VASIR, BALDEV, LAYBUTT, ROSS, HASENKAMP, WENDY, BONNERWEIR, SUSAN, and WEIR, GORDON C.
Subjects: Research, Diabetes research, Diabetes -- Research
Abstract: We have hypothesized that a loss of Β cell differentiation contributes to the marked alteration of glucose-induced insulin release in type 2 diabetes. We previously showed that, in islets from [...]
Published: 1999

26. Mucin-1 (MUC1) Oncoprotein in Multiple Myeloma Cells Inhibits the Th1 Responses By Down Regulating the Expression of Mir-200c and up-Regulating the PDL1 Expression

Author: Rajabi, Hasan, primary, Coll, Maxwell Douglas, additional, Rosenblatt, Jacalyn, additional, Yin, Li, additional, Stroopinsky, Dina, additional, Luptakova, Katarina, additional, Vasir, Baldev, additional, Pyzer, Athalia Rachel, additional, Palmer, Kristen, additional, Bar-Natan, Michal, additional, Jain, Salvia, additional, Somaiya, Poorvi, additional, Arnason, Jon, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2014
Full Text: View/download PDF

27. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metatastic Breast Cancer.

Author: DANA-FARBER CANCER INST BOSTON MA, Kufe, Donald, Vasir, Baldev, Avigan, David, DANA-FARBER CANCER INST BOSTON MA, Kufe, Donald, Vasir, Baldev, and Avigan, David
Abstract: The purpose of the study was to determine the effectiveness, safety, immunologic response, and clinical activity of vaccination with dendritic cell (DC)/breast cancer fusions administered in conjunction with IL-12 in patients with metastatic breast cancer. DC/breast carcinoma fusion cells present a broad array of tumor-associated antigens in the context of DC-mediated costimulation. Our pre-clinical studies showed that fusion of DCs with breast carcinoma cells up-regulates expression of costimulatory and maturation markers, results in high levels of expression of IL-12, and stimulates a mixed T cell response characterized by the expansion of both activated and regulatory T cell populations. Our results further showed that IL-12, IL-18, and TLR 9 agonist CpG oligodeoxynucleotides reduced the level of fusion- mediated regulatory T cell expansion and that sequential stimulation of fusion cells with anti-CD3/CD28 resulted in marker expansion of activated tumor-specific T cells. These findings indicated that DC/breast carcinoma fusions are effective in combination with IL-12 in activating antigen-specific T cells in clinical studies, vaccination of patients with metastatic breast cancer with fusion cells was well tolerated and induced immunologic responses. Combination of the vaccine with IL-12 was delayed by a lengthy review process, issues relating to the availability of IL-12 from the NCI and the challenge of enrolling patients with accessible tumor tissue for generating the vaccine. As a result, the present trial was closed and the plan is to develop this approach for breast cancer patients as adjuvant therapy following primary surgery., The original document contains color images.
Published: 2013

28. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metatastic Breast Cancer

Author: DANA-FARBER CANCER INST BOSTON MA, Kufe, Donald, Vasir, Baldev, Avigan, David, DANA-FARBER CANCER INST BOSTON MA, Kufe, Donald, Vasir, Baldev, and Avigan, David
Abstract: The main objective of the study is to determine the safety, immunologic response, and clinical effect of vaccination with dendritic cell (DC)/breast cancer fusions administered in conjunction with IL-12 to patients with metastatic breast cancer. DC/breast carcinoma fusion cells present a broad array of tumor-associated antigens in the context of DC-mediated costimulation. In clinical studies, vaccination with fusion cells was well tolerated, induced immunologic responses in a majority of patients, and resulted in disease regression in subset. We postulated that administration of the vaccine in conjunction with IL-12 would further enhance vaccine response by promoting T cell activation. In this study, we are conducting a phase I/II clinical trial in which patients with metastatic breast cancer undergo vaccination with DC/tumor fusions administered in conjunction with rhIL-12. An initial cohort of patients was treated with the DC/tumor fusions alone. In the subsequent cohort, fusion cells are being administered with rhIL-12 given subcutaneously at the time of vaccine administration and on days 3 and 5. Measures of tumor specific cellular and humoral immunity are being obtained at serial time points following vaccination. Time to disease progression and RECIST measurable disease response will be followed as a secondary endpoint.
Published: 2012

29. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metatastic Breast Cancer

Author: DANA-FARBER CANCER INST BOSTON MA, Kufe, Donald W., Avagan, David, Vasir, Baldev, DANA-FARBER CANCER INST BOSTON MA, Kufe, Donald W., Avagan, David, and Vasir, Baldev
Abstract: The overall objective of the project is to study the safety, immunologic response, and clinical effect of vaccination with dendritic cell (DC)/breast cancer fusions administered in conjunction with IL-12 in patients with metastatic breast cancer. Fusion of autologous tumor cells with DCs presents the entire repertoire of tumor antigens, including those yet to be identified, in the context of DC-mediated costimulation. The fusion cell vaccine allows for induction of helper T and CTL responses by class II presentation of exogenous protein and class I presentation of newly synthesized endogenous protein. Vaccination with fusion cells has eradicated established tumor in diverse animal models. In human MUC1 transgenic mice, vaccination with fusion cells reverses immunological unresponsiveness to MUC1 and results in the rejection of MUC1-positive tumors. Preclinical studies with patient-derived breast cancer cells and DCs have also demonstrated that fusion cells induce tumor-specific CTL responses and lysis of autologous tumor cells. In clinical studies, vaccination with fusion cells was well tolerated, induced immunologic responses in a majority of patients, and results in disease regression in subset of patients. We postulated that administration of the vaccine in conjunction with IL-12 would further enhance vaccine response by promoting T cell activation., The original document contains color images.
Published: 2010

30. Fusions of Breast Carcinoma and Dendritic Cells as a Vaccine for the Treatment of Metastatic Breast Cancer. Addendum

Author: DANA-FARBER CANCER INST BOSTON MA, Kufe, Donald W., Vasir, Baldev, Avigan, David, DANA-FARBER CANCER INST BOSTON MA, Kufe, Donald W., Vasir, Baldev, and Avigan, David
Abstract: The overall objective of the project is to study the safety, immunologic response, and clinical effect of vaccination with dendritic cell (DC)/breast cancer fusions administered in conjunction with IL-12 in patients with metastatic breast cancer. DC/breast carcinoma fusion cells present a broad array of tumor associated antigens in the context of DC-mediated co stimulation. Fusion cells stimulate tumor specific immunity with the capacity to lyse autologous tumor cells. In clinical studies, vaccination with fusion cells was well tolerated, induced immunologic responses in a majority of patients, and results in disease regression in subset of patients. We postulated that administration of the vaccine in conjunction with IL-12 would further enhance vaccine response by promoting T cell activation. In the first 3 years of the grant, we examined DC/breast carcinoma fusions with respect to their phenotypic characteristics as antigen presenting cells and their capacity to stimulate anti-tumor immunity. We demonstrated that DC/breast carcinoma fusions strongly express co stimulatory, adhesion, and maturation markers as well as the stimulatory cytokines, IL-12 and IFNgamma. In addition, fusion cells expressed CCR7 necessary for the migration of cells to sites of T cell traffic in the draining lymph nodes. In concert with these findings, fusions generated with immature and mature DCs potently stimulated CTL mediated lysis of autologous tumor targets.
Published: 2009

31. Clinical Trial Evaluating DC/AML Fusion Cell Vaccination in AML Patients Who Achieve a Chemotherapy-Induced Remission

Author: Rosenblatt, Jacalyn, primary, Stone, Richard M., additional, Uhl, Lynne, additional, Neuberg, Donna, additional, Vasir, Baldev, additional, Somaiya, Poorvi, additional, Joyce, Robin, additional, Levine, James D., additional, Boussiotis, Vassiliki A., additional, Zwicker, Jeffrey, additional, Arnason, Jon E., additional, Luptakova, Katarina, additional, Steensma, David P., additional, DeAngelo, Daniel J., additional, Galinsky, Ilene, additional, Delaney, Carol, additional, Mills, Heidi, additional, Breault, Emma, additional, Stroopinsky, Dina, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2014
Full Text: View/download PDF

32. MUC1 Expression Is Essential For Establishment Of Acute Myeloid Leukemia In Vivo

Author: Stroopinsky, Dina, primary, Rajabi, Hasan, additional, Rosenblatt, Jacalyn, additional, Mills, Heidi, additional, Kufe, Turner, additional, Luptakova, Katarina, additional, Vasir, Baldev, additional, Coll, Maxwell D, additional, Kristen, Palmer, additional, Kharbanda, Akriti, additional, Neeharika, Srivastava, additional, Joyce, Robin, additional, Levine, James D., additional, Arnason, Jon, additional, Stone, Richard M., additional, Pandolfi, Pier Paolo, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2013
Full Text: View/download PDF

33. Clinical Trial Evaluating DC/AML Fusion Cell Vaccination In AML Patients

Author: Rosenblatt, Jacalyn, primary, Stone, Richard M., additional, Uhl, Lynne, additional, Neuberg, Donna S., additional, Vasir, Baldev, additional, Somaiya, Poorvi, additional, Joyce, Robin, additional, Levine, James D., additional, Boussiotis, Vassiliki A., additional, Zwicker, Jeffrey I., additional, Arnason, Jon, additional, Luptakova, Katarina, additional, Steensma, David P., additional, DeAngelo, Daniel J., additional, Galinsky, Ilene, additional, Mills, Heidi, additional, Breault, Emma, additional, Delaney, Carol, additional, Stroopinsky, Dina, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2013
Full Text: View/download PDF

34. STAT3 Inhibition Promotes Potent Th1 Responses By Down Regulating Pdl-1 Expression On Tumor Cells

Author: Vasir, Baldev, primary, Rajabi, Hasan, additional, Mills, Heidi, additional, Rosenblatt, Jacalyn, additional, Stroopinsky, Dina, additional, Luptakova, Katarina, additional, Coll, Maxwell D, additional, Kristen, Palmer, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2013
Full Text: View/download PDF

35. Co-Expression Of The MUC1 Oncoprotein and CD34 On Primary Myeloma Bone Marrow Cells Identifies a Population With Myeloma Initiating Potential

Author: Luptakova, Katarina, primary, Rosenblatt, Jacalyn, additional, Stroopinsky, Dina, additional, Mills, Heidi, additional, Jakubikova, Jana, additional, Clohessy, John G, additional, Neeharika, Srivastava, additional, Vasir, Baldev, additional, Rajabi, Hasan, additional, Coll, Maxwell D, additional, Palmer, Kristen, additional, Arnason, Jon, additional, Zwicker, Jeffrey, additional, Joyce, Robin, additional, Hamdan, Ayad, additional, Levine, James D., additional, Mitsiades, Constantine S., additional, Anderson, Kenneth C., additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2013
Full Text: View/download PDF

36. MUC1 Is a Potential Target for the Treatment of Acute Myeloid Leukemia Stem Cells

Author: Stroopinsky, Dina, primary, Rosenblatt, Jacalyn, additional, Ito, Keisuke, additional, Mills, Heidi, additional, Yin, Li, additional, Rajabi, Hasan, additional, Vasir, Baldev, additional, Kufe, Turner, additional, Luptakova, Katarina, additional, Arnason, Jon, additional, Nardella, Caterina, additional, Levine, James D., additional, Joyce, Robin M., additional, Galinsky, Ilene, additional, Reiter, Yoram, additional, Stone, Richard M., additional, Pandolfi, Pier Paolo, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2013
Full Text: View/download PDF

37. Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients

Author: Rosenblatt, Jacalyn, primary, Avivi, Irit, additional, Vasir, Baldev, additional, Uhl, Lynne, additional, Munshi, Nikhil C., additional, Katz, Tami, additional, Dey, Bimalangshu R., additional, Somaiya, Poorvi, additional, Mills, Heidi, additional, Campigotto, Federico, additional, Weller, Edie, additional, Joyce, Robin, additional, Levine, James D., additional, Tzachanis, Dimitrios, additional, Richardson, Paul, additional, Laubach, Jacob, additional, Raje, Noopur, additional, Boussiotis, Vassiliki, additional, Yuan, Yan Emily, additional, Bisharat, Lina, additional, Held, Viki, additional, Rowe, Jacob, additional, Anderson, Kenneth, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2013
Full Text: View/download PDF

38. Targeting Leukemia Initiating Cells by MUC1-C Subunit Inhibition

Author: Stroopinsky, Dina, primary, Rosenblatt, Jacalyn, additional, Mills, Heidi, additional, Nardella, Caterina, additional, Ito, Keisuke, additional, Yin, Li, additional, Rajabi, Hasan, additional, Vasir, Baldev, additional, Kufe, Turner, additional, Luptakova, Katarina, additional, Arnason, Jon E., additional, Levine, James D., additional, Joyce, Robin, additional, Tzachanis, Dimitrios, additional, Boussiotis, Vassiliki A., additional, Galinsky, Ilene, additional, Stone, Richard M., additional, Reiter, Yoram, additional, Pandolfi, Pier Paolo, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2012
Full Text: View/download PDF

39. Transduction of Malignant Plasma Cells with Three Costimulatory Molecules (TRICOM) Elicits Myeloma-Specific Immune Response in Vitro – a Promising Strategy for Immunotherapy

Author: Luptakova, Katarina, primary, Mills, Heidi, additional, Rosenblatt, Jacalyn, additional, Stroopinsky, Dina, additional, Kufe, Turner, additional, Vasir, Baldev, additional, Arnason, Jon E., additional, Tzachanis, Dimitrios, additional, Joyce, Robin, additional, Levine, James D., additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2012
Full Text: View/download PDF

40. Blockade of PD-1 in Combination with Dendritic Cell/Myeloma Fusion Cell Vaccination Following Autologous Stem Cell Transplantation

Author: Rosenblatt, Jacalyn, primary, Avivi, Irit, additional, Vasir, Baldev, additional, Uhl, Lynne, additional, Katz, Tami, additional, Somaiya, Poorvi, additional, Mills, Heidi, additional, Joyce, Robin, additional, Levine, James D., additional, Tzachanis, Dimitrios, additional, Boussiotis, Vassiliki A., additional, Luptakova, Katarina, additional, Arnason, Jon E., additional, Drummy, Natalie, additional, Delaney, Carol, additional, Breault, Emma, additional, Held, Vicki, additional, Bisharat, Lina, additional, Giallombardo, Nancy, additional, Conway, Katharine, additional, Mortellite, Jamie, additional, Wagoner, Judith, additional, Schickler, Michael, additional, Rotem-Yehudar, Rinat, additional, Richardson, Paul G., additional, Laubach, Jacob P., additional, Munshi, Nikhil C., additional, Anderson, Kenneth C., additional, Rowe, Jacob M, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2012
Full Text: View/download PDF

41. Induction of Antitumor Immunity Ex Vivo Using Dendritic Cells Transduced With Fowl Pox Vector Expressing MUC1, CEA, and a Triad of Costimulatory Molecules (rF-PANVAC)

Author: Vasir, Baldev, primary, Zarwan, Corrine, additional, Ahmad, Rehan, additional, Crawford, Keith D., additional, Rajabi, Hassan, additional, Matsuoka, Ken-Ichi, additional, Rosenblatt, Jacalyn, additional, Wu, Zekui, additional, Mills, Heidi, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2012
Full Text: View/download PDF

42. Lenalidomide enhances anti-myeloma cellular immunity

Author: Luptakova, Katarina, primary, Rosenblatt, Jacalyn, additional, Glotzbecker, Brett, additional, Mills, Heidi, additional, Stroopinsky, Dina, additional, Kufe, Turner, additional, Vasir, Baldev, additional, Arnason, Jon, additional, Tzachanis, Dimitri, additional, Zwicker, Jeffrey I., additional, Joyce, Robin M., additional, Levine, James D., additional, Anderson, Kenneth C., additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2012
Full Text: View/download PDF

43. Addition of Clofarabine to TLI/ATG Conditioning: Impact on Immune Reconstitution and Clinical Outcomes,

Author: Glotzbecker, Brett, primary, Mills, Heidi, additional, Rosenblatt, Jacalyn, additional, Joyce, Robin, additional, Levine, James, additional, Tzachanis, Dimitrios, additional, Stevenson, Maryann, additional, Attar, Eyal C., additional, Ballen, Karen K., additional, Chen, Yi-Bin A., additional, Boussiotis, Vassiliki A, additional, Zwicker, Jeffrey, additional, Luptakova, Katarina, additional, Arnason, Jon E., additional, Bonhoff, Jessica, additional, Delaney, Carol, additional, Conway, Katharine, additional, Giallombardo, Nancy, additional, Mortellite, Jamie, additional, Glass, Jason, additional, Fitzgerald, Donna, additional, O'Brien, Stefanie, additional, McMahon, Caitlin, additional, Vasir, Baldev, additional, Stroopinsky, Dina, additional, Spitzer, Thomas R., additional, and Avigan, David, additional
Published: 2011
Full Text: View/download PDF

44. Clinical Trial Evaluating DC/AML Fusion Cell Vaccination Alone and in Conjunction with PD-1 Blockade in AML Patients Who Achieve a Chemotherapy-Induced Remission

Author: Rosenblatt, Jacalyn, primary, Stone, Richard M., additional, Avivi, Irit, additional, Uhl, Lynne, additional, Neuberg, Donna, additional, Joyce, Robin, additional, Tzachanis, Dimitrios, additional, Levine, James D., additional, Boussiotis, Vassiliki A, additional, Zwicker, Jeffrey, additional, Arnason, Jon E., additional, Luptakova, Katarina, additional, Steensma, David P., additional, DeAngelo, Daniel J, additional, Galinsky, Ilene, additional, Vasir, Baldev, additional, Somaiya, Poorvi, additional, Mills, Heidi, additional, Yuan, Yan Emily, additional, Bonhoff, Jessica, additional, Delaney, Carol, additional, Drummy, Natalie, additional, Nicholson, Lowell, additional, Stroopinsky, Dina, additional, Held, Vicki, additional, Katz, Tami, additional, Bisharat, Lina, additional, Rowe, Jacob M., additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2011
Full Text: View/download PDF

45. MUC1 Inhibition Reverses the Poor Immunogenicity of Leukemia Stem Cells Rendering Them Susceptible to Immunotherapy

Author: Stroopinsky, Dina, primary, Rosenblatt, Jacalyn, additional, Mills, Heidi, additional, Luptakova, Katarina, additional, Glotzbecker, Brett, additional, Vasir, Baldev, additional, Joyce, Robin, additional, Levine, James, additional, Tzachanis, Dimitrios, additional, Arnason, Jon E., additional, Galinsky, Ilene, additional, Stone, Richard M., additional, Kufe, Donald, additional, Reiter, Yoram, additional, and Avigan, David, additional
Published: 2011
Full Text: View/download PDF

46. PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine

Author: Rosenblatt, Jacalyn, primary, Glotzbecker, Brett, additional, Mills, Heidi, additional, Vasir, Baldev, additional, Tzachanis, Dimitrios, additional, Levine, James D., additional, Joyce, Robin M., additional, Wellenstein, Kerry, additional, Keefe, Whitney, additional, Schickler, Michael, additional, Rotem-Yehudar, Rinat, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2011
Full Text: View/download PDF

47. MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop

Author: Ahmad, Rehan, primary, Rajabi, Hasan, additional, Kosugi, Michio, additional, Joshi, Maya Datt, additional, Alam, Maroof, additional, Vasir, Baldev, additional, Kawano, Takeshi, additional, Kharbanda, Surender, additional, and Kufe, Donald, additional
Published: 2011
Full Text: View/download PDF

48. Lenalidomide Decreases PD-1 Expression, Depletes Regulatory T-Cells and Improves Cellular Response to a Multiple Myeloma/Dendritic Cell Fusion Vaccine In Vitro

Author: Luptakova, Katarina, primary, Glotzbecker, Brett, additional, Mills, Heidi, additional, Stroopinsky, Dina, additional, Vasir, Baldev, additional, Rosenblatt, Jacalyn, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2010
Full Text: View/download PDF

49. Targeting Acute Myeloid Leukemia Stem Cells by MUC1-C Subunit Inhibition

Author: Stroopinsky, Dina, primary, Rosenblatt, Jacalyn, additional, Ito, Keisuke, additional, Yin, Li, additional, Rajabi, Hasan, additional, Vasir, Baldev, additional, Kufe, Turner, additional, Glotzbecker, Brett, additional, Luptakova, Katarina, additional, Mills, Heidi, additional, Joyce, Robin, additional, Tzachanis, Dimitrios, additional, Boussiotis, Vassiliki A, additional, Levine, James, additional, Galinsky, Ilene, additional, Stone, Richard, additional, Pandolfi, Pier Paolo, additional, Kufe, Donald, additional, and Avigan, David, additional
Published: 2010
Full Text: View/download PDF

50. Survival of Human Multiple Myeloma Cells Is Dependent on MUC1 C-Terminal Transmembrane Subunit Oncoprotein Function

Author: Yin, Li, primary, Ahmad, Rehan, additional, Kosugi, Michio, additional, Kufe, Turner, additional, Vasir, Baldev, additional, Avigan, David, additional, Kharbanda, Surender, additional, and Kufe, Donald, additional
Published: 2010
Full Text: View/download PDF

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Database

Publisher

208 results on '"Vasir, Baldev"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources